# A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults

> **NCT00981175** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 202 (actual)

## Conditions studied

- Encephalitis
- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** Live attenuated Japanese encephalitis virus, then ChimeriVax diluent
- **BIOLOGICAL:** ChimeriVax diluent, then Live attenuated Japanese encephalitis virus

## Key facts

- **NCT ID:** NCT00981175
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2004-06
- **Final completion:** 2008-02
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2012-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981175, "A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00981175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*